Clinical trials: Locally Advanced or Metastatic Small Bowel Adenocarcinoma, open to volunteers

Locally Advanced or Metastatic Small Bowel Adenocarcinoma

Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma

• Recruiting
• Age: 18 years and older
• Phase 2
• Injection or infusion

Randomized, non-comparative, open-label, multi-centre Phase II study to evaluate modified FOLFIRINOX and modified FOLFOX in the locally advenced or metastatic small bowel adenocarcinoma.

Trial name

FOLFORINOX SBA (NCT06278545)

Testing

modified FOLFORINOX, Modified FOLFOX

Where

France

Volunteers

130 people

Sponsor

Centre Hospitalier Universitaire Dijon